Clinical Data Planning to Exit Genetic Testing Business to Fully Focus on Drug Development

Clinical Data, which at one point was working toward becoming a personalized medicine company, is now "considering the sale of its genetic testing and biomarker development business."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.